NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice
1996

L-NAME Reduces Tumor Growth and Capillary Leakage in Mice

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): A Orucevic, PK Lala

Primary Institution: The University of Western Ontario

Hypothesis

Can NG-nitro-L-arginine methyl ester (L-NAME) prevent interleukin 2-induced capillary leakage in tumor-bearing mice without compromising the therapeutic benefits of IL-2?

Conclusion

L-NAME effectively reduced tumor growth and the severity of IL-2-induced capillary leakage in some organs without compromising the anti-tumor efficacy of IL-2 therapy.

Supporting Evidence

  • L-NAME significantly reduced IL-2-induced pulmonary edema and water retention in the spleen.
  • L-NAME therapy alone did not induce pleural effusion in any of the animals.
  • Addition of L-NAME to IL-2 therapy did not compromise the anti-tumor effects of IL-2.

Takeaway

L-NAME is a medicine that helps stop leaks in blood vessels caused by another medicine called IL-2, which helps fight cancer. It also helps shrink tumors.

Methodology

C3H/HeJ female mice were treated with IL-2 and various doses of L-NAME, and the effects on capillary leakage and tumor growth were measured.

Limitations

Some animals died from IL-2 toxicity, affecting the sample size for the second round of therapy.

Participant Demographics

C3H/HeJ female mice, 6-7 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication